Cancer-suppressor protein p53 has undergone dramatic shifts in understanding over the past 30 years, but now scientists are entering a new era in the development of novel p53-based therapies.
A new book by A*STAR's Edison Liu and Douglas Lauffenburger of the Massachusetts Institute of Technology explores systems complexity in biomedical research.
Page
Get the PDF delivered to your inbox.
By entering your email, you also agree to be added to the A*STAR Research mailing list.
Get the PDF delivered to your inbox.
By entering your email, you also agree to be added to the A*STAR Research mailing list.
Join our mailing list
Stay up to date with the latest research highlights from A*Star.